LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC)

CUSIP: 519345102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / CLASS A COM
Total 13F shares
11,137,012
Share change
+1,004,396
Total reported value
$116,151,360
Price per share
$10.43
Number of holders
54
Value change
+$10,653,132
Number of buys
15
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 519345102?
CUSIP 519345102 identifies LVAC - LAVA MEDTECH ACQUISITION COR - CLASS A COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) as of Q1 2023

As of 31 Mar 2023, LAVA MEDTECH ACQUISITION COR - CLASS A COM (LVAC) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,137,012 shares. The largest 10 holders included Saba Capital Management, L.P., Periscope Capital Inc., Shaolin Capital Management LLC, Polar Asset Management Partners Inc., Castle Creek Arbitrage, LLC, Westchester Capital Management, LLC, Governors Lane LP, MARSHALL WACE, LLP, Balyasny Asset Management L.P., and TORONTO DOMINION BANK. This page lists 54 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.